A fully-automated bioreactor to culture human-induced pluripotent stem cells (hiPSCs) long-term has been developed by researchers at the Fraunhofer Translational Center for Regenerative Therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback